These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1398255)

  • 1. [Pharmacologic developments for the therapeutic use of biological response modifiers].
    Schröder W; Bender HG
    Gynakologe; 1992 Aug; 25(4):258-67. PubMed ID: 1398255
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of biological modifiers regulating the immune response after trauma.
    Stahel PF; Smith WR; Moore EE
    Injury; 2007 Dec; 38(12):1409-22. PubMed ID: 18048034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of biological response modifiers in disease control.
    Campos M; Godson D; Hughes H; Babiuk L; Sordillo L
    J Dairy Sci; 1993 Aug; 76(8):2407-17. PubMed ID: 8408871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current developments in psychoneuroimmunology and psycho-oncology].
    Müller N
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):M82-6. PubMed ID: 8766494
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunotherapy in gynecologic oncology].
    Krebs D
    Zentralbl Gynakol; 1996; 118(10):578. PubMed ID: 8999715
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytokines: present and future therapeutic applications].
    De Benedetti F; Marseglia GL; Martini A; Burgio GR
    G Ital Chemioter; 1989; 36(1-3):17-27. PubMed ID: 2488909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological response modifiers in the treatment of immunoinflammatory diseases].
    Skov L; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2120-6. PubMed ID: 18565292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological Response Modifiers Programme and cancer chemotherapy.
    Oldham RK
    Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic response modifiers in cancer therapy: a review.
    Quesada JR
    Tex Med; 1989 Nov; 85(11):42-7. PubMed ID: 2686076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapies for gynecologic cancer.
    Bookman MA
    Curr Opin Oncol; 1995 Sep; 7(5):478-84. PubMed ID: 8541395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tipping the balance towards tolerance: the basis for therapeutic immune modulation by gold?
    Carey JB; Carey MA; Allshire A; van Pelt FN
    Autoimmunity; 2005 Sep; 38(6):393-7. PubMed ID: 16278143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological therapy for gynecologic malignancies.
    Bookman MA
    Cancer Treat Res; 1998; 95():115-47. PubMed ID: 9619282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined aspects of pregnancy and tumor immunology].
    Koldovsky U
    Zentralbl Gynakol; 1999; 121(4):185-9. PubMed ID: 10355095
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of data on gynecologic cancer cell lines: potential applications of ATP-cell viability assays.
    Nguyen HN; Sevin BU; Perras JP; Averette HE
    Contrib Gynecol Obstet; 1994; 19():132-44. PubMed ID: 7995045
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of biological response modifiers in the treatment of cutaneous T-cell lymphoma.
    Rook AH; Yoo EK; Grossman DJ; Kao DM; Fox FE; Niu Z
    Curr Opin Oncol; 1998 Mar; 10(2):170-4. PubMed ID: 9555542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methods for evaluating biological response modifiers].
    Harousseau JL
    Bull Cancer; 1998 Dec; 85(12):993-6. PubMed ID: 9917552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A discussion of the results of chemotherapy on gynecological cancer and the host's immune response.
    Trelford JD
    Proc Natl Cancer Conf; 1970; 6():365-85. PubMed ID: 5458106
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological response modifiers in breast cancer.
    Janik JE; Longo DL
    Compr Ther; 1991 Dec; 17(12):28-31. PubMed ID: 1790662
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biotechnological pharmaceuticals and their potential use in inflammatory skin diseases].
    Villadsen L; Baadsgaard O
    Ugeskr Laeger; 2000 Dec; 162(50):6820-4. PubMed ID: 11187134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.